V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007268 | 330004068 | 1.72 | 67.1 | Curative (C) | 2016-01-16 | 2016-01-29 | CARBOPLATIN | N | N | 330008558 | CARBOPLATIN |
| 330007269 | 330004069 | 1.65 | 49.1 | null | 2014-01-11 | 2014-01-15 | Carboplatin AUC 6 - 10 | N | N | 330008562 | CARBOPLATIN |
| 330007270 | 330004070 | 1.53 | 43 | Palliative (P) | null | 2017-08-02 | OST Euramos 1 Closed Trial - M | N | N | 330008566 | METHOTREXATE HIGH DOSE |
| 330007271 | 330004073 | 1.77 | 63.7 | Neo-adjuvant (N) | null | 2015-04-19 | Cisplatin +Fluorouracil (2 wk) | N | N | 330008566 | CISPLATIN + FLUOROURACIL |
| 330007272 | 330004075 | 1.5 | null | Palliative (P) | 2016-12-26 | 2017-01-05 | Rituximab | 02 | N | 330008567 | RITUXIMAB |
| 330007273 | 330004075 | 1.62 | 43 | Neo-adjuvant (N) | 2015-10-09 | 2015-10-09 | Docetaxel + Gemcitabine (prior RT) | 2 | Y | 330008567 | DOCETAXEL + GEMCITABINE |
| 330007274 | 330004076 | 1.78 | 95.4 | Palliative (P) | 2015-03-19 | 2015-04-04 | CISPLATIN + FLUOROURACIL | N | N | 330008586 | CISPLATIN + FLUOROURACIL |
| 330007275 | 330004078 | 1.57 | 93.2 | Neo-adjuvant (N) | 2017-02-06 | 2017-04-18 | Docetaxel + Gemcitabine (prior RT) | N | N | 330008592 | DOCETAXEL + GEMCITABINE |
| 330007276 | 330004079 | 1.65 | 92.7 | Palliative (P) | null | 2016-02-18 | Cetuximab 7 day (Cycle 1) | 2 | N | 330008594 | CETUXIMAB |
| 330007277 | 330004080 | 1.75 | 71.8 | Neo-adjuvant (N) | 2017-04-20 | 2017-04-20 | MAP | N | N | 330008603 | MAP |
| 330007278 | 330004081 | 1.66 | 54 | null | 2015-07-01 | 2015-07-02 | Cetuximab 14 day | 2 | N | 330008603 | CETUXIMAB |
| 330007279 | 330012395 | 1.76 | null | Curative (C) | 2018-01-27 | 2018-01-27 | Etoposide + Ifosfamide (5 days) | null | N | 330008614 | ETOPOSIDE + IFOSFAMIDE |
| 330007280 | 330013160 | 1.74 | 76.2 | Palliative (P) | 2013-01-31 | 2013-03-20 | CISPLATIN + FLUOROURACIL | N | N | 330008639 | CISPLATIN + FLUOROURACIL |
| 330007282 | 330004084 | 1.62 | 85 | Curative (C) | 2016-02-23 | 2016-05-17 | CARBOPLATIN | N | N | 330008651 | CARBOPLATIN |
| 330007283 | 330008226 | 1.66 | 88 | Palliative (P) | 2013-12-21 | 2013-12-21 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 330008666 | CISPLATIN + FLUOROURACIL |
| 330007284 | 330008226 | 1.65 | 54 | Curative (C) | 2016-09-24 | 2016-09-24 | Docetaxel + Gemcitabine with GCSF | N | N | 330008666 | DOCETAXEL + GEMCITABINE |
| 330007285 | 330008226 | 1.57 | 51.2 | Disease modification (D) | 2017-11-06 | 2017-11-06 | MAP | N | N | 330008666 | MAP |
| 330007286 | 330008226 | 1.83 | 61.5 | null | null | 2015-04-30 | Carboplatin AUC 2 - 5 | N | N | 330008666 | CARBOPLATIN |
| 330007287 | 330004086 | 1.72 | 74.9 | Palliative (P) | 2013-12-13 | 2014-03-07 | Cetuximab 7 day (>Cycle 2) | N | N | 330008704 | CETUXIMAB |
| 330007288 | 330004088 | null | 87 | Disease modification (D) | 2018-04-18 | 2018-04-23 | OST Euramos 1 Closed Trial - M | N | N | 330008707 | METHOTREXATE HIGH DOSE |
| 330007289 | 330010462 | 1.7 | 82.5 | Palliative (P) | 2015-12-20 | 2016-01-04 | Etoposide + Ifosfamide (3 days) | N | Y | 330008719 | ETOPOSIDE + IFOSFAMIDE |
| 330007290 | 330011700 | 1.6 | 57.2 | Palliative (P) | 2017-07-09 | 2017-07-09 | Rituximab | N | null | 330008721 | RITUXIMAB |
| 330007291 | 330004089 | 1.78 | 47.9 | Neo-adjuvant (N) | 2015-11-10 | 2015-11-16 | Etoposide + Ifosfamide (5 days) | N | N | 330008733 | ETOPOSIDE + IFOSFAMIDE |
| 330007292 | 330004090 | 1.91 | 64.1 | Neo-adjuvant (N) | 2017-03-18 | 2017-03-18 | ETOPOSIDE + IFOSFAMIDE | N | N | 330008744 | ETOPOSIDE + IFOSFAMIDE |
| 330007293 | 330004090 | 1.58 | 27.5 | null | 2016-07-01 | 2016-07-02 | OST Euramos 1 Closed Trial - M | N | N | 330008744 | METHOTREXATE HIGH DOSE |
| 330007294 | 330004090 | 1.7 | 105.4 | Curative (C) | 2015-03-29 | 2015-03-30 | CISPLATIN + FLUOROURACIL | N | null | 330008744 | CISPLATIN + FLUOROURACIL |
| 330007295 | 330004091 | null | null | Neo-adjuvant (N) | 2013-07-03 | 2013-07-17 | MAP | N | null | 330008764 | MAP |
| 330007296 | 330004092 | 1.69 | 69 | Not known (9) | 2013-12-12 | 2014-06-21 | MAP | 2 | N | 330008764 | MAP |
| 330007297 | 330004092 | 1.59 | 41.3 | Palliative (P) | 2015-05-22 | 2015-06-05 | CARBOPLATIN | N | N | 330008764 | CARBOPLATIN |
| 330007298 | 330004092 | 1.59 | 52.2 | Disease modification (D) | 2018-09-02 | 2018-09-17 | ETOPOSIDE + IFOSFAMIDE | N | N | 330008764 | ETOPOSIDE + IFOSFAMIDE |
| 330007299 | 330004093 | 1.62 | null | Neo-adjuvant (N) | 2018-01-11 | 2018-01-13 | Docetaxel + Gemcitabine (prior RT) | 2 | N | 330008810 | DOCETAXEL + GEMCITABINE |
| 330007300 | 330004096 | 1.82 | 84 | Palliative (P) | 2015-05-08 | 2015-05-08 | Cetuximab 7 day (Cycle 1) | N | N | 330008813 | CETUXIMAB |
| 330007301 | 330004097 | null | 64.5 | Palliative (P) | 2017-06-02 | 2017-07-12 | DOCETAXEL + GEMCITABINE | N | N | 330008821 | DOCETAXEL + GEMCITABINE |
| 330007303 | 330004100 | 1.8 | 93 | null | 2015-02-17 | 2015-04-04 | Cetuximab 7 day (>Cycle 2) | N | Y | 330008835 | CETUXIMAB |
| 330007304 | 330004101 | 1.76 | 72 | Neo-adjuvant (N) | 2014-05-19 | 2014-07-06 | Docetaxel + Gemcitabine (prior RT) | N | N | 330008859 | DOCETAXEL + GEMCITABINE |
| 330007305 | 330004102 | 0 | 82.4 | Palliative (P) | 2016-09-16 | 2016-09-30 | Rituximab (Maintenance) | N | N | 330008865 | RITUXIMAB |
| 330007306 | 330004102 | 1.78 | 63.9 | Palliative (P) | 2015-08-20 | 2016-01-11 | Rituximab | 2 | N | 330008865 | RITUXIMAB |
| 330007307 | 330004103 | null | null | Palliative (P) | 2014-06-20 | 2014-07-29 | Rituximab | 02 | N | 330008887 | RITUXIMAB |
| 330007308 | 330004103 | 1.78 | 88 | Palliative (P) | 2015-01-16 | 2015-01-16 | ETOPOSIDE + IFOSFAMIDE | 2 | N | 330008887 | ETOPOSIDE + IFOSFAMIDE |
| 330007309 | 330004103 | 1.75 | 66.4 | Palliative (P) | 2014-09-27 | 2014-11-03 | Rituximab | 02 | N | 330008887 | RITUXIMAB |
| 330007310 | 330004104 | 1.55 | 18.3 | Neo-adjuvant (N) | 2016-02-29 | 2016-03-07 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 330008903 | CISPLATIN + FLUOROURACIL |
| 330007311 | 330008239 | 1.62 | null | Palliative (P) | 2016-09-22 | 2016-10-10 | CISPLATIN + FLUOROURACIL | null | null | 330008905 | CISPLATIN + FLUOROURACIL |
| 330007312 | 330004108 | 1.62 | 54 | Palliative (P) | 2018-01-23 | 2018-01-25 | Carboplatin AUC 6 - 10 | 02 | N | 330008907 | CARBOPLATIN |
| 330007315 | 330004112 | null | 82 | Curative (C) | 2014-06-03 | 2014-10-17 | Rituximab | 02 | N | 330008927 | RITUXIMAB |
| 330007316 | 330004113 | 1.78 | 90.6 | null | 2018-01-30 | 2018-02-01 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | 330008940 | MAP |
| 330007317 | 330004113 | null | 63.7 | Curative (C) | 2014-06-26 | 2014-06-29 | CARBOPLATIN | 02 | N | 330008940 | CARBOPLATIN |
| 330007318 | 330004113 | 1.6 | 51.3 | Curative (C) | 2013-09-23 | 2013-12-21 | Docetaxel + Gemcitabine (prior RT) | N | N | 330008940 | DOCETAXEL + GEMCITABINE |
| 330007319 | 330004115 | null | 83.4 | Neo-adjuvant (N) | 2015-11-09 | 2015-11-09 | Docetaxel + Gemcitabine (prior RT) | N | Y | 330008951 | DOCETAXEL + GEMCITABINE |
| 330007320 | 330004120 | null | null | Palliative (P) | null | 2017-12-12 | Cetuximab 7 day (>Cycle 2) | null | null | 330008953 | CETUXIMAB |
| 330007321 | 330012400 | null | 44.3 | Palliative (P) | 2016-04-22 | 2016-04-22 | Carboplatin AUC 2 - 5 | N | N | 330008964 | CARBOPLATIN |